The role of new biomarkers in acute kidney injury detecting in critical condition patients

V. Kh. Sharipova, N.F. Berdiev Berdiev, O. K. Lutfullaev Lutfullaev, A Mikhliev

Shoshilinch tibbiyot axborotnomasi · 2021-yil

Annotatsiya

Acute kidney injury is a polyetiologic syndrome that is a sudden decrease in kidney function over several days or weeks, causing the accumulation of nitrogenous compounds in the blood, with or without a decrease in urine output. Acute kidney injury is common in hospitalized patients and is associated with increased morbidity, mortality, and financial costs. Currently, acute kidney injury is diagnosed after the onset of symptoms; Available diagnostic tests (presence of creatinine in the blood, microscopy of urine, urine volume) have shortcomings in identifying subclinical acute kidney injury. The lack of therapeutic strategies leads to the fact that the treatment of acute kidney injury is carried out with the help of supportive therapies. Early acute kidney injury detection is essential to minimize damage. Experimental and clinical studies have identified a new biomarker that contribute to the earlier diagnosis of acute kidney injury. With their help, it can be determined that patients are at risk of acute kidney damage. In this review, the authors describe some of the most promising new AKI biomarkers (neutrophil gelatinase-associated lipocalin (NGAL), kidney injury molecule (KIM-1), interleukin-18 (IL18), tissue inhibitor of metalloproteinase-2 (TIMP-2), protein -7, which binds insulin-like growth factor (IGFBP7)).

Maqola ma’lumotlari
MualliflarV. Kh. Sharipova, N.F. Berdiev Berdiev, O. K. Lutfullaev Lutfullaev, A Mikhliev
JurnalShoshilinch tibbiyot axborotnomasi
NashriyotЎзбекистон шошилинч тиббий ёрдам врачлари, ассоциацияси
ISSN2010-9881
Nashr sanasi2021-09-20
Jild14
Son3
TilIngliz
Ilmiy sohaTibbiyot
DOI10.54185/tbem/vol14_iss3/a10
Indeksga qo‘shilgan2026-09-02

DOI: 10.54185/tbem/vol14_iss3/a10 · Maqolaning asl sahifasi · PDF

Ilmiy soha

Tibbiyot

Iqtibos keltirish

APAV. Kh. Sharipova, N.F. Berdiev Berdiev, O. K. Lutfullaev Lutfullaev, & A Mikhliev (2021). THE ROLE OF NEW BIOMARKERS IN ACUTE KIDNEY INJURY DETECTING IN CRITICAL CONDITION PATIENTS. Shoshilinch tibbiyot axborotnomasi, 14(3). https://doi.org/10.54185/tbem/vol14_iss3/a10
GOST (OAK)V. Kh. Sharipova va b. THE ROLE OF NEW BIOMARKERS IN ACUTE KIDNEY INJURY DETECTING IN CRITICAL CONDITION PATIENTS // Shoshilinch tibbiyot axborotnomasi. – 2021. – T. 14, № 3. – DOI: 10.54185/tbem/vol14_iss3/a10.
MLAV. Kh. Sharipova, N.F. Berdiev Berdiev, O. K. Lutfullaev Lutfullaev, and A Mikhliev. “THE ROLE OF NEW BIOMARKERS IN ACUTE KIDNEY INJURY DETECTING IN CRITICAL CONDITION PATIENTS.” Shoshilinch tibbiyot axborotnomasi, 14(3), 2021. https://doi.org/10.54185/tbem/vol14_iss3/a10
ChicagoV. Kh. Sharipova, N.F. Berdiev Berdiev, O. K. Lutfullaev Lutfullaev, and A Mikhliev. “THE ROLE OF NEW BIOMARKERS IN ACUTE KIDNEY INJURY DETECTING IN CRITICAL CONDITION PATIENTS.” Shoshilinch tibbiyot axborotnomasi, 14(3) (2021). https://doi.org/10.54185/tbem/vol14_iss3/a10
HarvardV. Kh. Sharipova, N.F. Berdiev Berdiev, O. K. Lutfullaev Lutfullaev, and A Mikhliev (2021) ‘THE ROLE OF NEW BIOMARKERS IN ACUTE KIDNEY INJURY DETECTING IN CRITICAL CONDITION PATIENTS’, Shoshilinch tibbiyot axborotnomasi, 14(3). https://doi.org/10.54185/tbem/vol14_iss3/a10
BibTeX
@article{vkhsharipova2021,
  title = {THE ROLE OF NEW BIOMARKERS IN ACUTE KIDNEY INJURY DETECTING IN CRITICAL CONDITION PATIENTS},
  author = {V. Kh. Sharipova and N.F. Berdiev Berdiev and O. K. Lutfullaev Lutfullaev and A Mikhliev},
  journal = {Shoshilinch tibbiyot axborotnomasi},
  year = {2021},
  volume = {14},
  number = {3},
  doi = {10.54185/tbem/vol14_iss3/a10},
  url = {https://doi.org/10.54185/tbem/vol14_iss3/a10}
}

Boshqa maqola uchun iqtibos tayyorlash

Shoshilinch tibbiyot axborotnomasi jurnalidan boshqa maqolalar

Shoshilinch tibbiyot axborotnomasi — barcha maqolalar · 2021-yil arxivi

Tibbiyot sohasidagi boshqa maqolalar

Tibbiyot sohasidagi OAK jurnallari